Massive potential share overhang upon conversion of the various preferred and warrants will likely pressure VTAK stock. Monitor for any selling stockholder resales post-S-1 effectiveness; the company's limited cash and going-concern risk make additional dilutive financing likely. The Series C-3 close is conditioned on S-1 effectiveness — watch for that trigger. The CEO's ~71% potential voting control creates governance risk and may deter new investors.
Executive Summary
Catheter Precision (VTAK) filed an S-1 registration statement covering the resale of 68,067,042 shares of common stock by selling stockholders, representing massive potential dilution (approximately 96% of post-issuance shares vs. the current 2.7M outstanding). The shares are issuable upon conversion of Series C-1/C-2/C-3/D/J convertible preferred stock and Series M warrants, much of which were issued in connection with private financings and the acquisition of FLYTE (private aviation). The company has a going-concern opinion from its auditor, only ~$0.4M cash as of March 31, 2026, an $18.5M working capital deficit, and two business segments (cardiac electrophysiology and private aviation) with negligible revenue.
Key Facts
- S-1 registers 68,067,042 shares for resale by selling stockholders, vs. only 2,692,473 shares currently outstanding — potential dilution of ~25x current float.
- Company has substantial doubt about its ability to continue as a going concern, with ~$0.4M cash and an $18.5M working capital deficit as of March 31, 2026.
- Private aviation segment generated only ~$0.2M revenue in Q1 2026; the FLYTE acquisition added defaulted debt and a $5.0M promissory note due December 2026.
- Series C-3 Preferred Stock remains unissued pending S-1 effectiveness; an additional $77.8M in Series C-4 Preferred Stock can be elected by purchasers.
- CEO and affiliates (Jenkins/FatBoy) control all Series J Preferred and Series M Warrants, and would hold ~71% voting control if all registered shares were issued and not resold.
Financial Impact
Up to ~$64.7M in maximum aggregate offering price (based on $0.95/sh filing fee table), but zero proceeds to the company — dilutive overhang only.
Risk Factors
- Extreme dilution: up to 68M new shares vs. 2.7M outstanding could depress stock price significantly.
- Going-concern risk: only $0.4M cash, $18.5M working capital deficit, and defaulted FLYTE debt.
- Related-party conflicts: CEO controls all Series J and Series M securities, could exercise controlling voting power.
- Restrictive covenants in Financing Purchase Agreement may block additional capital raises.
- Private aviation business unproven with minimal revenue and regulatory/operational risks.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1 Filing (Primary) | 0001437749-26-021318 |
| Exhibit: ex_979348.htm | 0001437749-26-021318 |
| Exhibit: ex_978765.htm | 0001437749-26-021318 |
| Exhibit: ex_978990.htm | 0001437749-26-021318 |
| Document: 0001437749-26-021318-index-headers.html | 0001437749-26-021318 |
| Document: 0001437749-26-021318-index.html | 0001437749-26-021318 |
| Document: 0001437749-26-021318.txt | 0001437749-26-021318 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | 8-K | $1.00 $0.8200 | ▲ +18.00% | ▲ +16.51% | $0.6500 (+35.00%) |
Oct 5, 2026 22d ago | Press Release | $1.62 $1.00 | ▼ −38.27% | ▼ −38.69% | $0.6500 (−59.88%) |
Oct 2, 2026 24d ago | 8-K | $1.62 $1.00 | ▼ −38.27% | ▼ −38.69% | $0.6500 (−59.88%) |
Oct 2, 2026 24d ago | Press Release | $1.62 $1.00 | ▼ −38.27% | ▼ −38.69% | $0.6500 (−59.88%) |
Sep 28, 2026 29d ago | Press Release | $0.1467 | awaiting T+5 | — | $0.6500 (+343.08%) |
Sep 25, 2026 4w ago | 8-K | $0.1467 | awaiting T+5 | — | $0.6500 (+343.08%) |
Aug 27, 2026 8w ago | Press Release | $0.2027 $0.1966 | ▼ −3.01% | ▼ −3.28% | $0.6500 (+220.67%) |
Aug 11, 2026 11w ago | Press Release | $0.2900 $0.2229 | ▼ −23.14% | ▼ −22.73% | $0.6500 (+124.14%) |
Aug 4, 2026 12w ago | Press Release | $0.2760 $0.2930 | ▲ +6.16% | ▲ +6.26% | $0.6500 (+135.51%) |
Jul 13, 2026 15w ago | EFFECT | $0.6504 $0.5020 | ▲ +22.82% | ▲ +21.87% | $0.6500 (+0.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers